CFO · OptimizeRx Corp (OPRX)

Douglas Baker

A named executive officer of OptimizeRx in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$449,528

Salary $240,000Stock awards $130,600Bonus $67,728

FY2018: $425,696

4th of 4 named executive officers at OptimizeRx by FY2019 total.

4 named officers on file for OptimizeRx, FY2019

Douglas Baker’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • OPRX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how OptimizeRx’s whole pay program stands against its peers

  • OptimizeRx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OPRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 1, 2020 (DEF 14A).

Free

Get Douglas Baker’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Douglas Baker compensation by year

OptimizeRx Summary Compensation Table · all 3 fiscal years held
In US dollars, as OptimizeRx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$200,000$220,000$240,000
Bonus$95,330$124,696$67,728
Stock awards$0$70,000$130,600
Option awards$134,070$0$0
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$9,794$11,000$11,200
Total$439,194$425,696$449,528

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OptimizeRx Corp DEF 14A filed October 1, 2020, accession 0001213900-20-029583, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OptimizeRx Corp filed document, accession 0001213900-20-029583. Every figure is read from that document and cited to the page and table it appears in. Filed October 1, 2020.

$439K
$426K
$450K
FY17
FY18
FY19
SalaryBonusStock awardsOption awardsAll other

OptimizeRx’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Stephen SilvestroChief Commercial Officer$1,120,199
William FebboCEO, Director$833,990
Miriam ParamorePresident$462,350
Douglas Baker · this pageCFO$449,528

The full OptimizeRx compensation record

free company brief

This page is one person within OptimizeRx's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the OptimizeRx proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OptimizeRx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Douglas Baker's compensation dossier · One-time report. No refunds.